121 related articles for article (PubMed ID: 31646551)
1. LncRNA TUG1 aggravates the progression of cervical cancer by binding PUM2.
Duan W; Nian L; Qiao J; Liu NN
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8211-8218. PubMed ID: 31646551
[TBL] [Abstract][Full Text] [Related]
2. LncRNA DANCR aggravates the progression of ovarian cancer by downregulating UPF1.
Pei CL; Fei KL; Yuan XY; Gong XJ
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10657-10663. PubMed ID: 31858532
[TBL] [Abstract][Full Text] [Related]
3. Low expression of TUG1 promotes cisplatin sensitivity in cervical cancer by activating the MAPK pathway.
Wei X; Zhou Y; Qiu J; Wang X; Xia Y; Sui L
J BUON; 2019; 24(3):1020-1026. PubMed ID: 31424656
[TBL] [Abstract][Full Text] [Related]
4. CircAGFG1 aggravates the progression of cervical cancer by downregulating p53.
Wang XH; Li J
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1704-1711. PubMed ID: 32141537
[TBL] [Abstract][Full Text] [Related]
5. lncRNA PICART1 alleviates progression of cervical cancer by upregulating TCF21.
Zhao Y; Dong X; Hou R
Oncol Lett; 2020 Jun; 19(6):3719-3724. PubMed ID: 32382324
[TBL] [Abstract][Full Text] [Related]
6. LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis.
Xu T; Liu CL; Li T; Zhang YH; Zhao YH
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4698-4705. PubMed ID: 31210308
[TBL] [Abstract][Full Text] [Related]
7. LncRNA FOXD2-AS1 accelerates the progression of cervical cancer via downregulating CDX1.
Chen DZ; Wang TF; Dai WC; Xu X; Chen PF
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10234-10240. PubMed ID: 31841177
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of long noncoding RNA TUG1 promotes cervical cancer cell proliferation and migration.
Hu Y; Sun X; Mao C; Guo G; Ye S; Xu J; Zou R; Chen J; Wang L; Duan P; Xue X
Cancer Med; 2017 Feb; 6(2):471-482. PubMed ID: 28088836
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA 00152 promotes cell proliferation in cervical cancer via regulating miR-216b-5p/HOXA1 axis.
Zheng JJ; Du XJ; Wang HP; Zhou LY; Wang YJ; Zhang L; Xu H; Zhang J; Hu ZF
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3654-3663. PubMed ID: 31114990
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression.
Jiang H; Hu X; Zhang H; Li W
Radiat Oncol; 2017 Apr; 12(1):65. PubMed ID: 28376901
[TBL] [Abstract][Full Text] [Related]
11. The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382.
Zhao L; Sun H; Kong H; Chen Z; Chen B; Zhou M
Cell Physiol Biochem; 2017; 42(6):2145-2158. PubMed ID: 28813705
[TBL] [Abstract][Full Text] [Related]
12. Exosomal taurine up-regulated 1 promotes angiogenesis and endothelial cell proliferation in cervical cancer.
Lei L; Mou Q
Cancer Biol Ther; 2020 Aug; 21(8):717-725. PubMed ID: 32432954
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1.
Zhang X; Zhao X; Li Y; Zhou Y; Zhang Z
J Cell Physiol; 2019 Aug; 234(10):17494-17504. PubMed ID: 30912129
[TBL] [Abstract][Full Text] [Related]
14. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling.
Liang S; Zhang S; Wang P; Yang C; Shang C; Yang J; Wang J
Gene; 2017 Apr; 608():49-57. PubMed ID: 28119088
[TBL] [Abstract][Full Text] [Related]
15. LncRNA SNHG14 promotes the development of cervical cancer and predicts poor prognosis.
Zhang YY; Li M; Xu YD; Shang J
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3664-3671. PubMed ID: 31114991
[TBL] [Abstract][Full Text] [Related]
16. LncRNA-CTS promotes metastasis and epithelial-to-mesenchymal transition through regulating miR-505/ZEB2 axis in cervical cancer.
Feng S; Liu W; Bai X; Pan W; Jia Z; Zhang S; Zhu Y; Tan W
Cancer Lett; 2019 Nov; 465():105-117. PubMed ID: 31499118
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of long non-coding RNA LINC00518 inhibits cervical cancer proliferation and metastasis by modulating JAK/STAT3 signaling.
Wang DW; You D; Dong J; Liu TF
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):496-506. PubMed ID: 30720156
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA NORAD upregulate SIP1 expression to promote cell proliferation and invasion in cervical cancer.
Huo H; Tian J; Wang R; Li Y; Qu C; Wang N
Biomed Pharmacother; 2018 Oct; 106():1454-1460. PubMed ID: 30119219
[TBL] [Abstract][Full Text] [Related]
19. Linc-UBC1 stimulates the metastasis and progression of ovarian cancer via downregulating p53 level.
Liu H; Zeng SY; Xie Y; Fei CQ; Sun L
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1054-1061. PubMed ID: 32096175
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of lncRNA CALML3-AS1 promotes cell proliferation and metastasis in cervical cancer via activation of the Wnt/β-catenin pathway.
Liu CN; Zhang HY; Liu CL; Wang CC
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5611-5620. PubMed ID: 31298313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
